713 filings
Page 2 of 36
6-K
7eb 8xhiozyv06c4dzqd
13 Oct 23
Current report (foreign)
4:08pm
6-K
5ixmq4nifa0hp8 bo
11 Oct 23
Kazia Announces Voluntary Delisting from Asx
7:35am
6-K
s2oy 58uiag3at8ws
10 Oct 23
Current report (foreign)
3:04pm
6-K
zbsasrmvs8lm8at3jb
6 Oct 23
Current report (foreign)
7:00am
6-K
zzoqeae3nll20py221rd
29 Sep 23
Kazia Therapeutics Announces Acceptance of
7:00am
6-K
aih592 5t
5 Sep 23
Current report (foreign)
7:02am
6-K
rncfun6bj2a
11 Aug 23
Kazia Therapeutics Announces Change to Board of Directors
7:00am
6-K
l885iv4z
6 Jul 23
Current report (foreign)
4:15pm
6-K
vii9cj69tgw8k 99v
26 Jun 23
Kazia Corporate Update and Corporate Presentation
7:00am
6-K
buebb6d h0ix
5 Jun 23
Kazia Expands Board of Directors with Appointment of Ebru Davidson
7:35am
6-K
0d1 hvuzlmzj1paj
1 May 23
Kazia Announces Executive Leadership Changes
7:14am
6-K
ygzzge7
14 Apr 23
Current report (foreign)
7:49am
6-K
zqnr2 ybq
4 Apr 23
Kazia Presents New Data for Paxalisib and EVT801
7:32am
6-K/A
kzd097yfwc9ub
9 Mar 23
2. Results for announcement to the market
7:32am
6-K
8jpsee0
7 Mar 23
Kazia Therapeutics Announces Clinical Collaboration for Australian Phase Ii Precision Medicine Study of Paxalisib In Childhood Cancers
7:40am
6-K
ldk30 msk522wpqha5e
28 Feb 23
2. Results for announcement to the market
4:18pm
6-K
yov88vrank09hty
24 Feb 23
Results of Egm
4:30pm
6-K
28s1pto
24 Feb 23
Current report (foreign)
7:35am
6-K
mjaew
20 Jan 23
Current report (foreign)
7:59am
6-K
557rm5b unh9mlgy78ix
17 Jan 23
Current report (foreign)
8:24am